We hypothesized that this common CASR polymorphism may be relevant in the pathophysiology of IBS and evaluated rs1801725 in patients with IBS from three case–control cohorts from the UK, Belgium and the USA. The gene discussed is CASR; the disease is irritable bowel syndrome.